comparemela.com
Home
Live Updates
Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights : comparemela.com
Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
– Topline data from ongoing Phase 1/2 trials of INZ-701 in adults with ABCC6 Deficiency and ENPP1 Deficiency expected in early April –– Phase 1 tr...
Related Keywords
Massachusetts ,
United States ,
Boston ,
American ,
Douglasa Treco ,
Stefan Riley ,
Christine Obrien ,
Inozyme Pharma ,
Matt Pera ,
Sagar Nigwekar ,
European Calcified Tissue Society Congress ,
Corporate Communications ,
Exchange Commission ,
Facebook ,
American Society Of Nephrology ,
Nasdaq ,
Company Or Inozyme ,
Kidney Research Center ,
Inozyme Pharma Inc ,
Development Rd Expenses ,
Linkedin ,
Twitter ,
Patient Registry ,
Christineo Brien ,
Hemodialysis Now Underway ,
American Society ,
Kidney Week ,
Massachusetts General ,
Early April ,
Year Ended December ,
Financial Guidance ,
Private Securities Litigation Reform Act ,
Annual Report ,
Quarterly Report ,
Ended December ,
comparemela.com © 2020. All Rights Reserved.